Ophthalmology Management

Ophthalmology Management Ophthalmology Management provides the tools ophthalmologists need to grow their practices, including

👁️ It’s Blindness Awareness Month!The Foundation Fighting Blindness has launched its 2025 Share Your Vision campaign — a...
10/07/2025

👁️ It’s Blindness Awareness Month!

The Foundation Fighting Blindness has launched its 2025 Share Your Vision campaign — a nationwide effort to amplify the voices of people living with vision loss, their families, caregivers, and researchers.

Each week in October, the campaign will spotlight a different theme — from How I See the World and Raising Our Voices to Breaking the Myths — reminding us that blindness exists on a spectrum, and that hope through research is stronger than ever.

💬 Ambassadors like Paralympic swimmer Anastasia Pagonis, content creator Eavan O’Neill, and advocate Lance Johnson will share their powerful stories to broaden public understanding and inspire change.

💛 Learn more about the campaign and how you can get involved: https://ow.ly/Nrlb50X7RzN

Change is at the heart of ophthalmology practice management—but lasting success depends on how it’s implemented.At ASOA/...
10/06/2025

Change is at the heart of ophthalmology practice management—but lasting success depends on how it’s implemented.

At ASOA/ASCRS 2025, the Aii in Action program was launched as a practical framework to help administrators turn new ideas into sustainable practice improvements.

🔹 Adoption: Aligning providers, staff & leadership
🔹 Implementation: Planning, training & resources
🔹 Integration: Embedding change into daily workflows

Supported by 6 infrastructure pillars—from staffing to education—this blueprint helps practices avoid common pitfalls and deliver meaningful, lasting results.

Explore how to apply the Aii model to your practice in Ophthalmology Management: https://ow.ly/LFsn50X6fyx

👁 A breakthrough for presbyopia care is here!Lenz Therapeutics  has announced that Vizz, the first FDA-approved aceclidi...
10/03/2025

👁 A breakthrough for presbyopia care is here!

Lenz Therapeutics has announced that Vizz, the first FDA-approved aceclidine-based eye drop for presbyopia, is now available in the US.

✔️ Samples are already being distributed nationwide to eye care professionals.
✔️ Consumer shipments begin in October through their ePharmacy partner, with retail pharmacies to follow later this year.
✔️ In phase 3 trials, 93% of patients achieved 20/40 or better near vision within 30 minutes — lasting up to 10 hours.

👉 Full story: https://ow.ly/SYTA50X53f4

Your website is often a patient’s first impression of your practice. Are you making the most of it?In this article, Rich...
10/01/2025

Your website is often a patient’s first impression of your practice. Are you making the most of it?

In this article, Richard Zimbalist, OD, FAAO, explains how smart internal linking can improve SEO, enhance navigation, and keep patients engaged:

✔️ Clear pathways to key pages
✔️ Descriptive, keyword-rich link text
✔️ Content that connects patients to services

Read more here: https://ow.ly/fFg350X2cb4

👓 Big news in pediatric eye care: The FDA has cleared Essilor Stellest lenses – the first eyeglasses in the US proven to...
09/30/2025

👓 Big news in pediatric eye care: The FDA has cleared Essilor Stellest lenses – the first eyeglasses in the US proven to both correct and slow the progression of myopia in children.

📊 Clinical data:
✔️ 71% slower myopia progression
✔️ 53% less eye elongation (vs single-vision lenses)
✔️ Safe, with only mild visual disturbances reported

This expands treatment beyond contact lenses, opening access for younger patients (ages 6–12) and giving families a new, non-invasive option. With myopia projected to affect 50% of the global population by 2050, the stakes couldn’t be higher.

👉 Read more about what this means for the future of myopia care in Ophthalmology: https://ow.ly/bXRv50X3wbT

👁 Big step forward in rare eye disease treatment!The U.S. Food and Drug Administration has accepted idebenone (Raxone) f...
09/29/2025

👁 Big step forward in rare eye disease treatment!

The U.S. Food and Drug Administration has accepted idebenone (Raxone) for Priority Review for Leber hereditary optic neuropathy (LHON).

If approved, idebenone would be the first FDA-approved therapy for LHON in the US.

Already available in the EU, UK, Israel, South Korea, and other regions, idebenone has demonstrated clinically meaningful improvements in visual acuity across multiple genetic variants in pivotal trials.

👉 Learn more about this milestone in Ophthalmology Management: https://ow.ly/oru450X1EiT

Middle managers are the backbone of ophthalmology practices. But too often, they are promoted without the tools they nee...
09/26/2025

Middle managers are the backbone of ophthalmology practices. But too often, they are promoted without the tools they need to thrive.

In Ophthalmology Management, John B. Pinto and Corinne Z. Wohl share 10 practical steps to help middle managers grow their skills, boost performance, and strengthen practice culture.

From skill-building plans to conflict management coaching, these strategies are about more than management—they are about retention, morale, and long-term stability.

👉 Read the full article: https://ow.ly/z8eH50WZgQV

👁️ Mark your calendars: World Sight Day is October 9.Prevent Blindness is hosting a series of national events aligned wi...
09/24/2025

👁️ Mark your calendars: World Sight Day is October 9.

Prevent Blindness is hosting a series of national events aligned with this year’s theme, “Love Your Eyes.” Programming includes:
✔️ A free national webinar on thyroid eye disease
✔️ Vision screenings & eye health education in Washington, D.C.
✔️ A Congressional Briefing on children’s vision and eye health
✔️ Free educational toolkits for schools and families

💬 “Collectively, our efforts help ensure that people everywhere can enjoy the precious gift of sight.” – Jeff Todd, President & CEO, Prevent Blindness

📖 Read the full article via Ophthalmology Management: https://ow.ly/iYAr50WZm51

👁️ Image of the MonthA 49-year-old patient with pigmentary glaucoma presented with multiple risk factors and early-to-mo...
09/23/2025

👁️ Image of the Month

A 49-year-old patient with pigmentary glaucoma presented with multiple risk factors and early-to-moderate VF loss. Using the Optos MonacoPro, Dr. Howard Barnebey captured ultra-widefield imaging and OCT scans in a single session — revealing peripheral changes and supporting confident monitoring of disease progression.

See the case details here 👉 https://ow.ly/6buy50WZgHm

🔬 New research presented at   reveals that patients with psoriasis face a higher risk of developing age-related macular ...
09/22/2025

🔬 New research presented at reveals that patients with psoriasis face a higher risk of developing age-related macular degeneration (AMD) — but biologic therapies may lower that risk by 27% compared with topical treatments.

Both wet and dry forms of AMD were elevated, with stronger associations for the vision-threatening wet type. The findings highlight a possible shared pathway through lipid dysregulation — and suggest biologics could deliver benefits beyond skin health.

📖 Read the full article via Ophthalmology Management: https://ow.ly/XGGf50WZlRW

Promising news in gene therapy for Usher syndrome type 1B. ✨At EURETINA 2025 in Paris, AAVantgarde Bio shared updated Ph...
09/19/2025

Promising news in gene therapy for Usher syndrome type 1B. ✨

At EURETINA 2025 in Paris, AAVantgarde Bio shared updated Phase 1/2 data from its LUCE-1 trial of AAVB-081. The therapy was well tolerated and showed functional vision improvements, including gains in visual acuity and fixation stability.

👉 Read the full results here: https://ow.ly/HbhB50WVS34

📖 “The Holy Grail of Cataract Surgery,” by Dr. Despoina Theotoka and Dr. Kendall E. Donaldson, explores the latest in ac...
09/17/2025

📖 “The Holy Grail of Cataract Surgery,” by Dr. Despoina Theotoka and Dr. Kendall E. Donaldson, explores the latest in accommodating IOLs designed to restore full-range vision in pseudophakic patients.

The article in Ophthalmology Management highlights promising innovations, emerging designs, and what’s still needed to achieve reliable outcomes.

👉 Read the full article to learn where current research stands and what the next steps are in cataract surgery innovation. https://ow.ly/Zeee50WVTj8

Address

400 N. Ashley Drive , Ste 2600
Tampa, FL
33602

Alerts

Be the first to know and let us send you an email when Ophthalmology Management posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram